The Clindamycin Phosphate in Dextros, cataloged under National Stock Number 6505-01-316-5044, is classified within Federal Supply Class 6505 (Drugs and Biologicals) of the Medical, Dental, and Veterinary Equipment group. The manufacturer of record is Sandoz Inc.. Government technical data includes 4 specifications, cited from the U.S. Government catalog. The record lists 2 manufacturer part numbers for this item, enabling identification through both NSN and commercial part number lookups. 4 additional reference documents (drawings, advisory and superseded references) are recorded in the U.S. Government catalog. Current acquisition status: Active. Unit of issue: PG.
| Parameter | Value |
|---|---|
| NSN | 6505-01-316-5044 |
| Primary Part Number | NDC00781-3289-09 |
| Item Name | Clindamycin Phosphate in Dextros |
| FSC / FSG | 6505 / 65 — Drugs and Biologicals |
| Manufacturer | Sandoz Inc. |
| Status | ACTIVE |
| Primary Container Content Quantity | 50.000 MILLILITERS |
| Primary Container Type | BAG WITH HANGING DEVICE, PLASTIC |
| Active Medicament Medicinal Strength | 600.000 MILLIGRAMS CLINDAMYCIN EQUIVALENT |
| Total Primary Container Quantity | 24 |
| Acquisition Status | ACTIVE |
| DEMIL Code | DEMIL A — No Demilitarization Required |
| Hazard | Hazardous per DLA record (HMIC Y) |
| Criticality Code | X |
| Unit of Issue | PG |
| Part Number | Manufacturer |
|---|---|
| NDC00781-3289-09 PRIMARY | Sandoz Inc. (USA) |
| 2G3453 PRIMARY | Baxter Healthcare Corporation (USA) |
| Reference | Meaning |
|---|---|
| NDC00338-3612-24 | 3/1 Design control — primary reference Baxter Healthcare Corporation |
| CLEOCIN INJECTION | 5/9 Secondary reference U.S. Government activity |
| NDC00009-3375-02 | 5/9 Secondary reference U.S. Government activity |
| CLEOCIN INJECTION | 5/1 Secondary reference Pfizer Pharmaceuticals |
NSN 6505-01-316-5044 is a Clindamycin Phosphate in Dextros, manufactured by Sandoz Inc., classified under FSC 6505, Drugs and Biologicals. Status: active.
NSN 6505-01-316-5044 has 2 manufacturer part numbers on file: NDC00781-3289-09 (Sandoz Inc.), 2G3453 (Baxter Healthcare Corporation).
Key specifications for NDC00781-3289-09: Primary Container Content Quantity: 50.000 MILLILITERS; Primary Container Type: BAG WITH HANGING DEVICE, PLASTIC; Special Features: CLINDAMYCIN PHOSPHATE INJECTION USP IN 5% DEXTROSE, 600 MG/50 ML BAGS, 24S. LIQUID PREMIX. STORE AT 20 TO 25 C (68 TO 77 F) [SEE USP CONTROLLED ROOM TEMPERATURE]. AVOID TEMPERATURES ABOVE 30 C.; Part Name Assigned by Controlling Agency: CLINDAMYCIN PHOSPHATE IN DEXTROSE INJECTION 50ML BAG 24S. 4 specifications are documented in the U.S. Government catalog.
Hazardous per DLA record (HMIC Y). Hazard information on this page is shown exactly as it appears in the DLA record.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-16.
U.S. Government catalog: edition PUBLOGDVD v12.0.0 (OCT 2026), edition date 2026-10-01, retrieved 2026-10-18.